Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors

By afschroeder • November 2, 2025

Wu M, Yang S, Yang Z, Fan J, Lomeli SH, Dharanipragada P, Moriceau G, Damoiseaux R, Kelley MC, Prieto-Granada CN, Giubellino A, Nosrati M, Kashani-Sabet M, Kim KB, Johnson DB, Liu S, Lo RS. Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors. Immunity. 2025 Oct 31:S1074-7613(25)00431-5. doi: 10.1016/j.immuni.2025.10.001. Epub ahead of print. PMID: 41175874.

Tags: acquired resistance, Anti-CTLA-4, Anti-PD-1, apoptosis sensitivity, copy-number variation, Dermatology, genomic evolution, immune checkpoint inhibitor, immune evasion, melanoma, Post Doc, Publications, single-cell whole-genome sequencing, T cell cytotoxicity, whole-exome sequencing

Related Posts

Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis

Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy[...]

The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma Elasticum

Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez-Del-Rio L,[...]

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction[...]